Total raised
$2.4M
Last: Undisclosed 2025-02
Stage
Seed
Founded
2019
Headcount
16
HQ
Or Yehuda
Sector
Health Tech & Life Sciences
About
PatenSee is a clinical-stage medical device company that has developed a contactless surveillance system designed to detect early asymptomatic vascular stenosis in hemodialysis patients.
By harnessing advanced multimodal imaging technologies and machine learning, PatenSee aims to flag stenosis risk at the earliest stage, enabling care teams to perform simple interventions to protect the patient’s hemodialysis lifeline, improve quality of care, and prolong life expectancy.
Funding history · 2 rounds · $2.4M total
2025-02
Undisclosed
$1.6M
2019-03
Seed
$750K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is PatenSee's core technology?
- PatenSee has developed a contactless surveillance system that uses advanced multimodal imaging technologies and machine learning to detect early asymptomatic vascular stenosis in hemodialysis patients.
- When was PatenSee founded?
- PatenSee was founded in March 2019.
- What was PatenSee's initial funding round?
- In March 2019, PatenSee raised a Seed round of $750,000. Investors included Israel Innovation Authority and MEDX Ventures Group.
- What was PatenSee's most recent funding round?
- In February 2025, PatenSee completed an Undisclosed Round, raising $1,600,000.
- What is PatenSee's total funding to date?
- PatenSee has raised a total of $2,350,000 across its funding rounds.
- What significant regulatory milestone did PatenSee achieve in September 2025?
- In September 2025, PatenSee received FDA Breakthrough Device Designation for its non-contact vascular access management system for hemodialysis patients.
- Did PatenSee sign any notable collaboration agreements in 2024?
- Yes, in February 2024, PatenSee and Fresenius Medical Care signed a clinical collaboration agreement.
- When did PatenSee initiate its first in-human clinical trial?
- PatenSee initiated its first in-human trial with its contactless imaging surveillance system for hemodialysis patients in February 2021.
- What were the results of PatenSee's clinical trial at Rabin Medical Center?
- In March 2022, PatenSee announced successful clinical trial results at Rabin Medical Center, demonstrating the promise of its contactless imaging device in monitoring dialysis patients.
- How many employees does PatenSee currently have?
- PatenSee currently has 11-50 employees, with an exact count of 16.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital Healthcare
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
early-detectionmedical-technologiesvascularremote-monitoringimagingdigital-healthcaredialysismedical-devicesmachine-learningartificial-intelligencehospitalsnon-invasive